Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0869020120150020072
Journal of Korean Orthopaedic Research Society
2012 Volume.15 No. 2 p.72 ~ p.75
Atypical Subtrochanteric Femoral Fracture in a Patient with Non-metatatic Breast Cancer on Zoledronic Acid Therapy - A Case Report -
Lee Dae-Hee

Lee Sang-Wook
Abstract
The bisphosphonate is known for its ability to reduce bone loss in osteoporotic and osseous metastatic conditions. The side effects have been reported after long-term bisphosphonate therapy. We report the case of a
woman who sustained atypical subtrochanteric femoral fracture while being on zoledronic acid(ZometaR, Novartis) therapy for more than 4 years.
KEYWORD
Atypical fracture , Breast cancer , Zoledronic acid
FullTexts / Linksout information
Listed journal information
KoreaMed